Circulating immune complexes in sera from patients receiving procainamide.
D000906:Antibodies; D000974:Antibodies, Antinuclear / Q000276:immunology; D000920:Antibody-Dependent Cell Cytotoxicity; D000936:Antigen-Antibody Complex; D002499:Centrifugation, Density Gradient; D006801:Humans; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008214:Lymphocytes / Q000276:immunology; D009203:Myocardial Infarction / Q000188:drug therapy; D011342:Procainamide / Q000627:therapeutic use*; D012217:Rheumatoid Factor
D000906:Antibodies; D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D012217:Rheumatoid Factor; D011342:Procainamide